Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression | Zendy

Eugene M. Tan | Zendy; Daniel C. DeSimone | Zendy; M. Rizwan Sohail | Zendy; Larry M. Baddour | Zendy; Walter R. Wilson | Zendy; James M. Steckelberg | Zendy; Abinash Virk | Zendy

Open Access

Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression

Author(s) -

Eugene M. Tan,

Daniel C. DeSimone,

M. Rizwan Sohail,

Larry M. Baddour,

Walter R. Wilson,

James M. Steckelberg,

Abinash Virk

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix181

Subject(s) - medicine , comorbidity , penicillin , confidence interval , trimethoprim , surgery , antibiotics , microbiology and biotechnology , biology

Most cardiovascular implantable electronic device (CIED) recipients are elderly, have multiple comorbid conditions, and are at increased risk of CIED infection (CIEDI). Current guidelines recommend complete device removal in patients with CIEDI to prevent relapse and mortality. However, comorbidities or other factors may preclude device removal, thus prompting a nonsurgical approach that includes chronic antibiotic suppression (CAS). There are limited data on outcomes of patients receiving CAS for CIEDI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research